Travere Therapeutics, Inc. Common Stock

TVTXNASDAQ • USD
50.34 USD
↘ 0.31 (0.61%)🟢LIVE (AS OF 10:02 AM EST)
🟢Market: OPEN

Travere Therapeutics, Inc. Common Stock (TVTX) trades at $50.34 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, TVTX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 13, 2026.

Open?$50.40
High?$51.33
Low?$49.54
Prev. Close?$50.65
Volume?34.9K
Avg. Volume?2.2M
VWAP?$50.45
Rel. Volume?0.02x
Bid / Ask
Bid?$43.38 × 100
Ask?$57.72 × 100
Spread?$14.34
Midpoint?$50.55
Valuation & Ratios
Market Cap?4.9B
Shares Out?96.0M
Float?90.2M
Float %?95.6%
P/E Ratio?N/A
P/B Ratio?215.29
EPS?-$1.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
Employees
497
Market Cap
4.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2003-07-23
Address
3611 VALLEY CENTRE DR
SAN DIEGO, CA 92130
Phone: 888-969-7879
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
27
Momentum?
14
Short Sent.?
65
Piotroski F-Score?3/9Weak
Altman Z-Score?1.74Distress
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.61%High
Short Interest?9.6M
Days to Cover?4.7
Free Float90.2M
Avg Daily Volume2.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.00Strong
Quick Ratio?2.95Strong
Cash Ratio?0.59Adequate
Debt/Equity?26.72High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
47/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
215.29HIGH▾
P/S?
Peers
100
S&P
15
7.47HIGH▾
P/FCF?
Peers
100
S&P
3
76.2PRICEY▾
EV/EBITDA?
S&P
97
-66.2CHEAP▾
EV/Sales?
Peers
100
S&P
16
8.21HIGH▾
Returns & Efficiency
ROE?
S&P
3
-538.0%WEAK▾
ROA?
S&P
3
-14.3%WEAK▾
Cash Flow & Enterprise
FCF?$63.8M
Enterprise Value?$5.3B
Fundamentals ratios updated end of day